PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
Volume 17, Issue 2

Survey of Obesity Developers Suggests Multi-Indication Approaches are Vital but Demanding

Following the rapid label expansion of drugs such as semaglutide and tirzepatide in recent years, drug developers have broadly adopted multi-indication strategies fo...
Continue Reading →
Volume 17, Issue 2

Outsourcing: The Key to Navigating Fill-Finish in Pharmaceutical Manufacturing 

The fill-finish phase in the pharmaceutical manufacturing industry is undergoing a significant transformation. Once primarily focused on the aseptic filling of vials...
Continue Reading →
Volume 17, Issue 2

The Importance of Uniform, High-quality Containers for Effective Drug Manufacturing 

To maintain efficiency and profitability in competitive marketplaces, pharmaceutical companies must adjust to ever-increasing complexity, stricter regulations, and g...
Continue Reading →
Volume 17, Issue 2

Depot Injection Formulation and Modelling – Part B 

Application for Formulation Scientists In developing an oil-based depot formulation, formulation scientists can leverage the understanding of diffusion principles an...
Continue Reading →
Volume 17, Issue 2

Successfully Transforming Regulatory Affairs Through Technology and Innovation 

Nick Littlebury, EVP, Regulatory Affairs at Coronado Research, discusses the latest trends in regulatory affairs and how companies can unlock the full potential of n...
Continue Reading →
Volume 17, Issue 2

AI Isn’t Replacing Doctors – It’s Making Their Prescriptions Smarter 

While AI doesn’t diagnose or treat patients directly, database expert Dominik Tomicevic says its growing use, alongside graph technology, is transforming how healthc...
Continue Reading →
Volume 17, Issue 2

From Data Silos to Streamlined Connectivity: How Biopharma Can Prepare for ESMP 

Sponsors that centralise their product information will not only help pre-empt drug shortages but also improve their own capacity for collaboration through connected...
Continue Reading →
Volume 17, Issue 2

Smart Custom Automation in Pharmaceutical Secondary Packaging: A Technical Perspective

Automation continues to be a key enabler in pharmaceutical manufacturing, not only in upstream processes like formulation and primary packaging but also in secondary...
Continue Reading →
Volume 17, Issue 2

Tracing the Source: Using AI to Unmask Counterfeiters in Real Time 

Counterfeiting is no longer a crude affair. Today’s fake products can closely mimic legitimate ones, infiltrating supply chains with concerning precision. Yet, for a...
Continue Reading →
Volume 17, Issue 2

Cold Chain in the Context of Global Warming 

Global distribution of life-saving pharmaceuticals is incredibly complex, with several different components from warehouse to final delivery. At each stage, provider...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026